← All stocks

BioXcel Therapeutics, Inc.

BTAI Net selling
CIK 0001720893 #4965 in the set updated 17 Sep 2026
Bought (120 mo)
$321.11K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$75.03M
$447.41K on a plan · $12.63M straight out of an exercise
Sold at will
$61.95M
23 of 106 sales
Net
−$74.70M
−$61.63M against sales at will

By person

11 insiders · 149 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mehta Vimal
CEO and President
$89.34K (21)
$18.86M (30)
−$18.77M
25,484,068
$27.70M
−7.8%
Nandabalan Krishnan
Director
$4.92K (1)
$17.85M (8)
−$17.84M
17,727,750
$19.27M
−4.6%
BioXcel Holdings, Inc. entity
10% owner
$14.59M (1)
−$14.59M
17,566,750
$19.10M
−3.5%
BioXcel LLC entity
10% owner
$14.59M (1)
−$14.59M
8,546,750
$9.29M
−6.9%
O'Neill Vincent
See Remarks
$4.82M (21) scheduled
−$4.82M
19,957
$21.69K
Yocca Frank
Chief Scientific Officer
$66.31K (5)
$3.85M (22)
−$3.79M
26,210
$28.49K
Steinhart Richard I
Chief Financial Officer
$7.60K (3)
$372.18K (10) scheduled
−$364.58K
26,335
$28.63K
MUELLER PETER
Director
$152.94K (12)
+$152.94K
258,320
$280.79K
+9.7%
Rodriguez Javier
See Remarks
$81.81K (9) scheduled
−$81.81K
26,838
$29.17K
Wiley Matthew T.
See Remarks
$6.56K (4) scheduled
−$6.56K
19,011
$20.66K
+1,801%
MACK DAVID J.
Director
20,317
$22.08K

No percentages here. This company's share count has moved by a factor of 7.8 over the window, from 5,486,038 to 42,748,364 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Mehta Vimal
5 Jun 2024
CEO and President
Sell indirect
126,014
$1.58
$199.62K
Mehta Vimal
5 Jun 2024
CEO and President
Sell indirect
283,122
no price
Mehta Vimal
4 Jun 2024
CEO and President
Sell indirect
126,014
$1.63
$205.52K
Mehta Vimal
4 Jun 2024
CEO and President
Sell indirect
283,123
no price
Mehta Vimal
4 Jun 2024
CEO and President
Sell indirect
609,221
no price
Rodriguez Javier
15 Mar 2023
See Remarks
Sell
950
$19.63
$18.64K
O'Neill Vincent
15 Mar 2023
Chief Medical Officer
Sell
845
$19.70
$16.64K
Yocca Frank
15 Mar 2023
Chief Scientific Officer
Sell
985
$19.69
$19.40K
Steinhart Richard I
15 Mar 2023
Chief Financial Officer
Sell
2,084
$19.50
$40.64K
Yocca Frank
20 Jan 2023
Chief Scientific Officer
Sell
50,000
$30.00
$1.50M
BioXcel Holdings, Inc.
25 Jun 2021
10% owner
Sell indirect
473,250
$30.83
$14.59M
BioXcel LLC
25 Jun 2021
10% owner
Sell
473,250
$30.83
$14.59M
Nandabalan Krishnan
25 Jun 2021
Director
Sell indirect
473,250
$30.83
$14.59M
Mehta Vimal
25 Jun 2021
CEO, President and Secretary
Sell indirect
473,250
$30.83
$14.59M
Yocca Frank
15 Mar 2021
Chief Scientific Officer
Sell
630
$49.30
$31.06K
Yocca Frank
15 Mar 2021
Chief Scientific Officer
Sell
14,370
$48.47
$696.51K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
600
$61.20
$36.72K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
1,772
$60.43
$107.08K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
500
$59.46
$29.73K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
2,886
$58.54
$168.95K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
1,137
$57.71
$65.62K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
6,805
$56.49
$384.41K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
1,300
$55.88
$72.64K

What was left out

Form 4 filings counted 230
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 41
Sales straight out of an exercise 42
Sales at will 23
Transactions with no price 3
Shares from compensation/vesting 2,968,409
Sales filed before the plan box existed 18
History held since 13 Mar 2018